Why is Boston Bio falling/rising?

As of 04-Jul, Boston Bio Systems Ltd is currently priced at 7.31, reflecting an increase of 0.06 or 0.83%. The stock has shown a trend reversal, gaining after 12 consecutive days of decline. Despite this recent uptick, it is still trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. In terms of performance, the stock has outperformed its sector by 0.87% today, and there has been a notable increase in investor participation, with delivery volume rising by 8.14% compared to the 5-day average. However, there are no available positive or negative factors to further explain the stock's recent movement.
In the broader market context, Boston Bio's performance over the past week shows a decline of 6.40%, while the Sensex has only decreased by 0.74%. Over the past month, Boston Bio has gained 2.67%, contrasting with the Sensex's increase of 3.01%. This indicates that while the stock is experiencing a short-term recovery, it has underperformed relative to the benchmark in the recent past. The liquidity of the stock remains adequate for trading, as it is based on 2% of the 5-day average traded value.